Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study-Reference-Cited by-同舟云学术

Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study

Published:2023-05 Issue: Volume:59 Page:101940
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Haude Michael,Wlodarczak Adrian,van der Schaaf René J.,Torzewski Jan^ORCID,Ferdinande Bert,Escaned Javier,Iglesias Juan F.,Bennett Johan^ORCID,Toth Gabor,Joner Michael,Toelg Ralph,Wiemer Marcus,Olivecrona Göran,Vermeersch Paul,Garcia-Garcia Hector M.,Waksman Ron

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. SICI-GISE position document on the use of the Magmaris resorbable magnesium scaffold in clinical practice;Galli;Cardiovasc Revasc Med,2022

2. 2018 ESC/EACTS Guidelines on myocardial revascularization;Neumann;EuroIntervention,2019

3. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial;Haude;Lancet,2016

4. Magnesium 2000 postmarket evaluation: guideline adherence and intraprocedural performance of a sirolimus-eluting resorbable magnesium scaffold;Wlodarczak;Cardiovasc Revasc Med,2019

5. Sustained safety and efficacy of magnesium reabsorbable scaffold. 2-year follow-up analysis from first Magmaris multicenter Italian registry;Galli;Cardiovasc Revasc Med,2022

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights and perspectives into biodegradable metals in cardiovascular stents: A mini review;Journal of Alloys and Compounds;2024-10

2. Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study;EuroIntervention;2024-09

3. Coronary Bioresorbable metallic stents:Advancements and future perspectives;Journal of Cardiology;2024-08

4. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

5. Optimal Pre-dilatation Treatment before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis. The OPTIMIS trial;2024-07-29